Verónica Cabreira , Martin Zeidler , Laura McWhirter , Suvankar Pal , Jon Stone , Alan Carson
{"title":"Functional cognitive disorder in Alzheimer's disease","authors":"Verónica Cabreira , Martin Zeidler , Laura McWhirter , Suvankar Pal , Jon Stone , Alan Carson","doi":"10.1016/j.jns.2025.123618","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To conduct a preliminary exploration of functional cognitive disorders (FCD) in the context of Alzheimer's disease (AD), and potential shared mechanisms.</div></div><div><h3>Methods</h3><div>Retrospective analysis of a convenience sample of FCD patients with an overlapping diagnosis of AD evaluated in two outpatient services in the United Kingdom, between 2010 and 2023. Demographics, latency until AD diagnosis, detailed description of FCD and AD, comorbidities, family history, imaging and fluid biomarkers, cognitive testing, symptom trajectory, and employment status were collected from hospital records. Possible clues for AD among FCD patients were explored by comparing FCD-AD cases against a sample of insidious onset FCD-only patients matched for age at symptom onset.</div></div><div><h3>Results</h3><div>Twelve FCD-AD cases were identified (eight female). All patients had FCD symptoms before or simultaneously with an AD diagnosis (median latency of 2.5 years). Low cognitive scores at baseline, sleep disturbance and/or mood and anxiety disorders were more common in the FCD-AD cases, in comparison with the FCD-only group. Informants' concern, executive, language and/or praxis difficulties, and an increase in repetitions may point to underlying AD. No cases appeared to be a misdiagnosis. Initial relative symptom stability or transient improvement, stressful life events around symptom onset and a family history of cognitive difficulties did not differentiate between FCD patients with or without AD.</div></div><div><h3>Discussion</h3><div>FCD may be a prodromal or presenting feature of AD. We discuss potential links between the two, and the clinical relevance of these findings for prognostication and management of FCD patients, including its implications for clinical trials.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"476 ","pages":"Article 123618"},"PeriodicalIF":3.2000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X25002357","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
To conduct a preliminary exploration of functional cognitive disorders (FCD) in the context of Alzheimer's disease (AD), and potential shared mechanisms.
Methods
Retrospective analysis of a convenience sample of FCD patients with an overlapping diagnosis of AD evaluated in two outpatient services in the United Kingdom, between 2010 and 2023. Demographics, latency until AD diagnosis, detailed description of FCD and AD, comorbidities, family history, imaging and fluid biomarkers, cognitive testing, symptom trajectory, and employment status were collected from hospital records. Possible clues for AD among FCD patients were explored by comparing FCD-AD cases against a sample of insidious onset FCD-only patients matched for age at symptom onset.
Results
Twelve FCD-AD cases were identified (eight female). All patients had FCD symptoms before or simultaneously with an AD diagnosis (median latency of 2.5 years). Low cognitive scores at baseline, sleep disturbance and/or mood and anxiety disorders were more common in the FCD-AD cases, in comparison with the FCD-only group. Informants' concern, executive, language and/or praxis difficulties, and an increase in repetitions may point to underlying AD. No cases appeared to be a misdiagnosis. Initial relative symptom stability or transient improvement, stressful life events around symptom onset and a family history of cognitive difficulties did not differentiate between FCD patients with or without AD.
Discussion
FCD may be a prodromal or presenting feature of AD. We discuss potential links between the two, and the clinical relevance of these findings for prognostication and management of FCD patients, including its implications for clinical trials.
期刊介绍:
The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).
JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.